1. Home
  2. ZWS vs CYTK Comparison

ZWS vs CYTK Comparison

Compare ZWS & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zurn Elkay Water Solutions Corporation

ZWS

Zurn Elkay Water Solutions Corporation

HOLD

Current Price

$46.20

Market Cap

8.0B

Sector

Industrials

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$63.34

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZWS
CYTK
Founded
1891
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
8.0B
IPO Year
2012
2004

Fundamental Metrics

Financial Performance
Metric
ZWS
CYTK
Price
$46.20
$63.34
Analyst Decision
Buy
Strong Buy
Analyst Count
6
16
Target Price
$47.50
$84.81
AVG Volume (30 Days)
1.0M
1.8M
Earning Date
02-03-2026
02-26-2026
Dividend Yield
0.95%
N/A
EPS Growth
42.52
N/A
EPS
1.12
N/A
Revenue
$1,659,400,000.00
$87,211,000.00
Revenue This Year
$8.97
$341.94
Revenue Next Year
$5.57
$75.44
P/E Ratio
$42.34
N/A
Revenue Growth
6.88
2609.26
52 Week Low
$27.74
$29.31
52 Week High
$50.03
$70.98

Technical Indicators

Market Signals
Indicator
ZWS
CYTK
Relative Strength Index (RSI) 44.70 49.19
Support Level $45.56 $62.13
Resistance Level $48.01 $65.88
Average True Range (ATR) 0.98 2.59
MACD -0.04 0.07
Stochastic Oscillator 27.52 54.84

Price Performance

Historical Comparison
ZWS
CYTK

About ZWS Zurn Elkay Water Solutions Corporation

Zurn Elkay Water Solutions Corp designs procures, manufactures, and markets a range of clean water solutions for drinking water, hygiene, and sustainable water management. The company's product portfolio includes professional-grade water control and safety, water distribution and drainage, drinking water, finish plumbing, hygienic, environmental and site works products for public and private spaces.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: